| Literature DB >> 32733301 |
Jonathan Journiac1, Christel Vioulac1, Anne Jacob1, Coline Escarnot1, Aurélie Untas1.
Abstract
Background: Studies interested in patients coping with a cardiac illness usually focus on children, teenagers, and adults above the age of 55. Apart from the field of congenital heart diseases, there is a general lack of literature regarding young adult cardiac patients (18-55 years old) who seem to cope with psychosocial issues. Therefore, the objective of this paper was to gather all the research carried out concerning the psychological experiences of young adult cardiac patients. Methods andEntities:
Keywords: adults; cardiac; experience; review; young
Year: 2020 PMID: 32733301 PMCID: PMC7358619 DOI: 10.3389/fpsyg.2020.01119
Source DB: PubMed Journal: Front Psychol ISSN: 1664-1078
Figure 1Flow diagram of the study selection.
Characteristics of the included studies.
| Quantitative | 23 |
| Qualitative | 5 |
| Quantitative and qualitative | 2 |
| Quantitative and visual | 2 |
| International (multi-country) | 12 |
| United States | 7 |
| Australia | 2 |
| Finland | 2 |
| Germany | 2 |
| United Kingdom | 3 |
| Czech Republic | 1 |
| Estonia | 1 |
| Israel | 1 |
| Sweden | 1 |
| Myocardial infarction/acute coronary syndrome | 19 |
| Coronary heart/artery disease | 7 |
| Cardiac catheterization | 2 |
| Cardiac arrest | 1 |
| Heart failure | 1 |
| Heart transplant | 1 |
| Peripartum cardiomyopathy | 1 |
Myocardial perfusion imaging.
Figure 2Time distribution of the included published articles on young adult cardiac patients' experience.
Detailed information on the included studies.
| Andersson et al. ( | 23–53 | 17 | 45 | MI | During the 1st year following their MI | Sweden | Qualitative (interpretative phenomenological analysis, IPA) | 85 | 83 |
| Beckman et al. ( | 18–55 | 3,437 | 47 | MI | Within 24 h after MI + 1 month + 12 months | USA and Spain | Quantitative | 85 | 83 |
| Brummett et al. ( | <55 | No data | No data | CAD (cardiac catheterization) | Hospitalization + 1 month post-catheterization + 3-month intervals over 2 years | USA | Quantitative | 63 | 73 |
| Bucholz et al. ( | 18–55 | 3,432 | 48 | MI | Initial hospitalization + 1 month + 12 months | USA and Spain | Quantitative | 88 | 83 |
| Deasy et al. ( | 29–41 | 56 | 35 | Cardiac arrest | 5 years after the event (range 2.7/8.6 years) | Australia | Quantitative | 75 | 80 |
| Dostálová et al. ( | <45 | 76 | No data | MI | <5 years after the event | Czech Republic | Quantitative | 60 | 58 |
| Dreyer et al. ( | 18–55 | 3,501 | 47 | MI | Hospitalization, 1 and 12 months post-AMI | USA and Spain | Quantitative | 83 | 88 |
| Dreyer et al. ( | 18–55 | 436 | No data | CAD (pre-MI) | Hospitalization | USA and Spain | Quantitative | 83 | 85 |
| Hinz et al. ( | 30–39/40–49 | 652 | No data | MI (or bypass) | At the beginning of their rehabilitation | Germany | Quantitative | 70 | 75 |
| Joubert et al. ( | <55 | 30 | 47.7 | MI | Hospitalization, 3 and 6 months | Australia | Quantitative and qualitative | 63 | 65 |
| Koutrolou-Sotiropoulou et al. ( | >18 | 116 | 36 | Peripartum cardiomyopathy (HF) | 0.2 to 24 years after the event | USA | Quantitative and qualitative | 65 | 68 |
| Lacharity ( | 31–47 | 11 | 40 | CAD | 4 months to 10 years after the event | USA | Qualitative (ethnographic) | 70 | 65 |
| Lavie and Milani ( | 22–54 | 104 | 48 | CAD | Baseline 2–6 weeks after CAD event + 1 week later | USA | Quantitative | 60 | 75 |
| Leung Yinko et al. ( | 18–55 | 1,123 | 49 | ACS | Baseline (48 h after admission) + 1 month + 6 months + 12 months | Canada, USA, and Switzerland | Quantitative | 73 | 80 |
| Leung Yinko et al. ( | 18–55 | 740 | 50 | ACS | 48 h after admission + 1 year later | Canada, USA, and Switzerland | Quantitative | 73 | 73 |
| Lindau et al. ( | 18–55 | 3,498 | 48 | MI | Hospitalization + 1 month post-MI | USA and Spain | Quantitative | 83 | 83 |
| Lindau et al. ( | 18–55 | 2,802 | 48 | MI | Hospitalization + 1 month post-MI + 1 year | USA and Spain | Quantitative | 80 | 83 |
| Lukkarinen and Hentinen ( | 35–54 | No data | No data | CHD | 1 or 2 years after medication prescribed for group 1; right before the surgery in the other groups | Finland | Quantitative | 65 | 65 |
| Lukkarinen and Hentinen ( | 35–54 | 80 | No data | CAD | 1 or 2 years after medication prescribed for group 1; right before the surgery in the other groups | Finland | Quantitative | 70 | 70 |
| McAnirn et al. ( | 35–47 | 7 | 42 | MI | 6–8 weeks after the event | UK | Qualitative (Heideggerian phenomenological) | 75 | 78 |
| Merritt et al. ( | 29–44 | 10 | 40.1 | MI | 116 mean days since MI | UK | Qualitative (IPA) | 90 | 88 |
| Pelletier et al. ( | 42–54 | 909 | 48 | ACS | Hospitalization (within 24 h of admission) + 12 months | Canada, USA, and Switzerland | Quantitative | 70 | 75 |
| Schweikert et al. ( | 45–54 | No data | No data | MI | 7.4 median years since first MI | Germany | Quantitative | 80 | 85 |
| Shah et al. ( | <55 | 851 | No data | CAD (angina, MI, and HF) | The day of or before cardiac catheterization | USA | Quantitative | 78 | 83 |
| Uusküla ( | 30–44 | 64 | 37.3, 38.6 | MI | Between 4 and 7 days after infarction | Estonia | Quantitative | 55 | 50 |
| Vaccarino et al. ( | 38–50 | 49 | No data | MI | Within 6 months (5 months median time) after the event | USA | Quantitative and visual | 73 | 78 |
| Vaccarino et al. ( | 34–50 | 68 | No data | CHD | At least 1 week after the event | USA | Quantitative and visual | 80 | 78 |
| Waldron et al. ( | 19–29 | 9 | No data | HT (dilated cardiomyopathy, restrictive cardiomyopathy, and previous medical treatments) | 7 months to 9.5 years (mean 3.6 years) after the event | UK | Qualitative (IPA) | 88 | 90 |
| Wong et al. ( | 20–39/40–49 | 658 | No data | HF (ICM, valvular, and ischemic HD) | At least 4 weeks after the event | USA and Canada | Quantitative | 68 | 65 |
| Xu et al. ( | 18–55 | 3,572 | MI | Baseline + 1 month | USA, Spain, and Australia | Quantitative | 75 | 85 | |
| Xu et al. ( | 18–55 | 3,509 | 47 | MI | Screening at baseline 3 days after admission + 1 month + 12 months | USA, Spain, and Australia | Quantitative | 85 | 90 |
| Zipori-Beckenstein et al. ( | 18–55 | 57 | No data | Cardiac catheterization | Right before catheterization and 6 weeks later | Israel | Quantitative | 63 | 63 |
MI, myocardial infarction; CHD, coronary heart disease; CAD, coronary artery disease; ACS, acute coronary syndrome; HF, heart failure; ICM, idiopathic cardiomyopathy; HT, heart transplant; HD, heart disease.
Questionnaires used in each quantitative study.
| Beckman et al. ( | PHQ-9 | PSS-14 | SF-12 and SAQ | SF-12 | SD | QC | ESSI | |||||
| Brummett et al. ( | PSS-10 | |||||||||||
| Bucholz et al. ( | PHQ-9 | SF-12 and SAQ | SF-12 | ESSI | ||||||||
| Deasy et al. ( | EQ-5D | EQ-5D | EQ-5D and SF-12 | EQ-5D and SF-12 | GOS-E and SF-12 | SF-12 and SD | ||||||
| Dostálová et al. ( | IIEF-5 | SAQ | Biological measures of statins, beta blockers, ACEi/ARBs, and antiplatelet therapy | |||||||||
| Dreyer et al. ( | EQ-5D | Item in sex questionnaire | SF-12, SAQ, and EQ-5D | EQ-5D and SF-12 | SAQ | SD | ||||||
| Dreyer et al. ( | EQ-5D | Item in sex questionnaire | SF-12, SAQ, and EQ-5D | EQ-5D and SF-12 | SAQ | SD | ||||||
| Hinz et al. ( | HADS | HADS | ||||||||||
| Joubert et al. ( | CDS | SF-12 | SF-12 | SF-12 and CPIEAS | ||||||||
| Koutrolou-Sotiropoulou et al. ( | QC | QC | QC | |||||||||
| Lavie and Milani ( | SF-36 | SF-36 | KSQ and SF-36 | SF-36 | ||||||||
| Leung Yinko et al. ( | HADS | HADS | Unclear | SF-12 and SAQ | SF-12 | ESSI | SD | |||||
| Leung Yinko et al. ( | HADS | HADS | FFQ, GSLPAQ, smoking characteristics, and alcohol consumption habits | |||||||||
| Lindau et al. ( | PHQ-9 | PSS | SF-12 | SF-12 | Items adapted from prior large-scale interviewer-administered studies of adult sexuality | QC | ||||||
| Lindau et al. ( | PHQ-9 | PSS | Items adapted from prior large-scale interviewer-administered studies of adult sexuality | QC | ||||||||
| Lukkarinen and Hentinen ( | NHP | NHP | NHP | NHP | SD | |||||||
| Lukkarinen and Hentinen ( | NHP | NHP | NHP | NHP | SD | |||||||
| Pelletier et al. ( | HADS | HADS | QC | Unclear | QC | |||||||
| Schweikert et al. ( | EQ-5D | EQ-5D | Unclear | EQ-5D and EQ-VAS | EQ-5D | |||||||
| Shah et al. ( | PHQ-9 | |||||||||||
| Uusküla ( | PARQ | Type A Finnish scale | ||||||||||
| Vaccarino et al. ( | BDI-II and SCI | STAI-T/S and visual analog ratings of anxiety | SUDS, PSS, blood pressure, and heart rate | ESSI | ||||||||
| Vaccarino et al. ( | BDI-II and SCI | STAI-T/S | SUDS, PSS, blood pressure, and heart rate | |||||||||
| Wong et al. ( | MLHFQ | Number of pills taken as prescribed | ||||||||||
| Xu et al. ( | EQ-5D | PSS-14, PSS-10, ISLES | SF-12 | SF-12, SAQ, and EQ-5D | EQ-5D and SF-12 | QC | ESSI | QC | ||||
| Xu et al. ( | EQ-5D | PSS-14, and ISLES | SAQ | ESSI | QC | |||||||
| Zipori-Beckenstein et al. ( | Teichman's questionnaire of trait and state anxiety and QC | QC | QC | QC |
SCI, Structured Clinical Interview for DSM IV; CDS, Cardiac Depression Scale; NHP, Nottingham Health Profile; SUDS, Subjective Units of Distress Scale; PSS, Cohen's Perceived Stress Scale; ISLES, INTERHEART Stressful Life Events Scale; KSQ, Kellner Symptom Questionnaire; SAQ, Seattle Angina Questionnaire; GOS-E, Glasgow Outcome Scale Extended; SF-12, Medical Outcomes Study Short-Form General Health Survey; HADS, Hospital Anxiety and Depression Scale; EQ-5D, EuroQoL 5 Dimensions; BDI-II, Beck Depression Inventory; IIEF-5, International Index of Erectile Function; FFQ, Food Frequency Questionnaire; GSLPAQ, Godin–Shephard Leisure-Time Physical Activity Questionnaire; CPIEAS, Computerized PIE Assessment Schedule; MLHFQ, Minnesota Living HF Questionnaire; QC, questionnaire created for the study; SD, sociodemographic questionnaire.
Themes explored in each qualitative study.
| Andersson et al. ( | x | x | x | x | x | x | x | x | x | x | x | x | ||
| Joubert et al. ( | x | x | x | x | x | |||||||||
| Koutrolou-Sotiropoulou et al. ( | x | x | x | |||||||||||
| Lacharity ( | x | x | x | x | x | x | x | x | x | x | x | |||
| McAnirn et al. ( | x | x | x | x | x | x | x | |||||||
| Merritt et al. ( | x | x | x | x | x | x | x | x | x | |||||
| Waldron et al. ( | x | x | x | x | x | x |
x, theme explored in this study.